Tesamorelin + Ipamorelin Blend
Body CompositionPremium GH optimization with visceral fat reduction and body recomposition.
GHRH analog (Tesamorelin) + selective GHRP (Ipamorelin): Tesamorelin provides potent GHRH stimulation with FDA-recognized visceral fat reduction; Ipamorelin amplifies GH pulse.
For athletes, the primary value of Tesamorelin + Ipamorelin Blend lies in its ability to premium gh optimization with visceral fat reduction and body recomposition.. This mechanism is particularly relevant during high-volume training phases when tissue repair demand exceeds the body's natural recovery capacity.
Variable — onset typically within 2–8 weeks depending on protocol and individual response.
Individual response varies based on injury severity, training load, and baseline health markers.
Well tolerated. Tesamorelin may cause injection site reactions. Monitor IGF-1 levels.
Always verify current WADA status with your sport's governing body before use in competition.
Falutz J, et al. N Engl J Med. 2007;357(23):2349-61.
Raun K, et al. Eur J Endocrinol. 1998;139(5):552-61.
Start a Tesamorelin + Ipamorelin Blend Protocol
Hatter Labs provides physician-supervised performance protocols with GMP-certified Tesamorelin + Ipamorelin Blend and comprehensive biomarker monitoring.
Get ProtocolStart Your Performance Protocol for Tesamorelin + Ipamorelin Blend
Hatter Labs provides physician-supervised performance protocols with GMP-certified compounds, biomarker testing, and personalized programs designed around your training goals.
HIPAA Compliant · GMP Certified · Physician Supervised